This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements. Additionally, competitive factors across CROs are analyzed with a special focus on leading CROs. An analysis of clinical trial trends and patterns across regions will allow CROs to understand where future growth opportunities may lie and allow them to further penetrate this dynamic and lucrative market.
Introduction
- Title
- Disclaimer
- Certification
- Table of Contents
Executive Summary
- Competing in the U.S. CRO Market
Objectives and Methodology
- Objectives of the Study
- Methodology
Outsourcing Patterns and Trends
- Percent of Pharmaceutical and Biotechnology Outsourcing - By Research Area
- Percent Clinical Development Outsourcing: Current and Future
- Research and Development Budget
- Percent R&D Budget Allocated to CRO Expenditures
- Percent Increase in CRO Budget Next 12-24 Months
- Percent Share of Phases in CRO Budget - Current and Projected
Motives and Perceived Benefits of Outsourcing
- Perceived Benefits of Outsourcing
CRO Utilization Satisfaction and Preferences
- Oncology
- Central Nervous System (CNS)
- Cardiovascular
- Metabolic Diseases
- Infectious Diseases
- Respiratory/Allergy
- Musculoskeletal/Arthritis
- Full-Service CRO Preferences
- Niche CRO Preferences
- Pre-Clinical Phase Preferences
- Phase I Preferences
- Phase II/III Preferences
- Phase IV Preferences
Market Segments and Criteria for CRO Selection
- Overall Criteria for CRO Selection (Satisfiers)
- Areas for Improvement: Current Top Sources of Dissatisfaction
- Derived vs. Stated Importance
- Derived vs. Stated Importance: Strategic Issues
- Derived vs. Stated Importance: Secret Issues
- Derived vs. Stated Importance: Non-Issues
- Derived vs. Stated Importance: Basic Requirements
- Market Segments - The 3 Types of CRO Services Users
- Criteria for CRO Selection by Market Segment
- Scope and Intensity of Outsourcing by Market Segment
- Perceived Benefits and Motives for Outsourcing by Market Segment
- R&D Budget Size by Market Segment
- CRO Budget Share of the R&D Budget by Market Segment
CRO Preference Metrics
- The Importance of CRO Performance Metrics
Perceived Attributes of CROs
- Relative Perceived Strengths of CROs - The Broad Competitive Landscape
An Evaluation of 11 Large CROs
- Brand Awareness and Preference of 11 Large CROs
- Brand Awareness of 11 Large CROs
- Brand Preference of 11 Large CROs
- Awareness and Conversion to Preference: 11 Large CROs
- A Note: The Potential Impact of the Acquisition of Charles River's Capabilities by Kendle
- Service Category vs Price Category Matrix
- Service Category vs. Price Category Matrix: The Value Frontier
- Relative Perceived Strengths of 11 Large CROs
Clinical Trial Trends Across Regions
- Clinical Trials Per Region - Current and Future 2006-2011
Other Technology Requirements: Current and Future
- Biomarkers Biologics and Biotechnology Needs - Current and Future
- IT Capabilities Expected from CROs - Current and Future
Purchase Behavior Patterns and Trends
- Average No. of CROs Invited per Request for Proposal (RFP) - By Phase
- Share of Outstanding Budget Among Most Utilized CROs
- Utilization of Data Collection Capabilities in Phase II-IV Trials
- Status of Pre-Clinical Drug Discovery Outsourcing to CROs
- Emerging Factors for Future CRO Selection - Next 5 Years
About Frost & Sullivan
- Frost & Sullivan
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements. Additionally, competitive factors across CROs are analyzed with a special focus on leading CROs. An analysis of clinical trial trends and patterns across regions will allow CROs to understand where future growth opportunities may lie and allow them to further penetrate this dynamic and lucrative market.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | N07A-01-00-00-00 |
| Is Prebook | No |
Competing in the U.S. Contract Research Market
Competing in the U.S. Contract Research Market
RELEASE DATE
30-Nov-2006
30-Nov-2006
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: N07A-01-00-00-00
SKU: HC01998-NA-MR_07286
$4,950.00
In stock
SKU
HC01998-NA-MR_07286